Ellington Financial
EFC · NYSE
About EFC
- Employees
- 500
- Headquarters
- Greenwich, Connecticut
- Listed
- Oct 8, 2010
- Sector
- Financials
- Industry
- Mortgage Real Estate Investment Trusts (REITs)
- Website
- ellingtonfinancial.com
EFC key statistics
- Market cap
- 1.48B
- Price-earnings ratio
- 7.05
- Dividend yield
- 14.02%
- Average volume
- 1.84M
- Volume
- 2.09M
- Open price
- $11.38
- High today
- $11.66
- Low today
- $11.37
- 52 Week high
- $14.12
- 52 Week low
- $11.28
Ellington Financial (EFC) at a glance
As of Oct 20, 2026, Ellington Financial (EFC) shares are priced at $11.48, giving the company a market cap of 1.48B, a price-to-earnings ratio of 7.05 and a dividend yield of 14.02%.
Today the stock has traded between $11.37 and $11.66. The current price is 1.0% above the day's low and 1.5% below its high.
Volume so far is 2.09M shares, in line with the average of 1.84M shares a day.
Over the past year Ellington Financial has ranged from $11.28 to $14.12, and now sits 7% of the way up that range.
Ellington Financial met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $0.60 per share against an estimate of $0.4848.
The average analyst price target is $15.15, 32.0% above the current price, from 3 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy33.3%
- Hold66.7%
- Sell0.0%
- Low
- $14.14
- Now
- $11.48
- High
- $16.80
EFC earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 7 of the last 8 quarters, by 16.3% on average.
- Q3 FY24: reported $0.40 per share against an estimate of $0.3676
- Q4 FY24: reported $0.45 per share against an estimate of $0.3824
- Q1 FY25: reported $0.39 per share against an estimate of $0.3953
- Q2 FY25: reported $0.47 per share against an estimate of $0.4026
- Q3 FY25: reported $0.53 per share against an estimate of $0.4427
- Q4 FY25: reported $0.47 per share against an estimate of $0.4545
- Q1 FY26: reported $0.55 per share against an estimate of $0.4444
- Q2 FY26: reported $0.60 per share against an estimate of $0.4848
EFC news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
Ellington Financial Announces Estimated Book Value Per Common Share as of August 31, 2026
- Press releaseBusiness Wire
Ellington Financial Closes Additional 7.375% Senior Unsecured Notes Offering
- Press releaseBusiness Wire
Ellington Financial Announces Upsizing and Pricing of Additional 7.375% Senior Unsecured Notes Due 2030
- Press releaseBusiness Wire
Ellington Financial Announces Proposed Offering of Senior Unsecured Notes
- Press releaseBusiness Wire
Ellington Financial Declares Common and Preferred Dividends
- Press releaseBusiness Wire
Moody’s Revises Ellington Financial’s Rating Outlook to Positive, Affirms Ba3 Corporate Family Rating
- Press releaseBusiness Wire
Ellington Financial Announces Estimated Book Value Per Common Share as of July 31, 2026
Similar companies
Companies in the same industry as Ellington Financial
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.